Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Graf

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
JCO Precision Oncology|July 12, 2022
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting TherapiesAmado J Zurita, Ryon P Graf, Guillermo Villacampa, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
The Journal of Arthroplasty|October 24, 2018
General Assembly, Research Caveats: Proceedings of International Consensus on Orthopedic InfectionsR Bargon, J Bruenke, Alberto Carli, et al.
Journal of Neurotrauma|April 7, 2026
Pathophysiology of the Post-Traumatic Confusional State and Post-Traumatic Amnesia: A Scoping ReviewDouglas I Katz, Yelena G Bodien, Afik Faerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate CancerPaymaneh D Malihi, Ryon P Graf, Angel Rodriguez, et al.
JAMA Oncology|July 7, 2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical TrialKaren A Autio, Robert Dreicer, Justine Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
JAMA Network Open|December 27, 2023
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational BurdenAndrea Necchi, Philippe E Spiess, Tiago Costa de Padua, et al.
The Oncologist|May 13, 2022
Variable Genomic Landscapes of Advanced Melanomas with Heavy PigmentationRichard S P Huang, Julie Y Tse, Lukas Harries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
JCO Precision Oncology|July 12, 2022
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting TherapiesAmado J Zurita, Ryon P Graf, Guillermo Villacampa, et al.
Cancer Research|August 19, 2017
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
The Journal of Arthroplasty|October 24, 2018
General Assembly, Research Caveats: Proceedings of International Consensus on Orthopedic InfectionsR Bargon, J Bruenke, Alberto Carli, et al.
Journal of Neurotrauma|April 7, 2026
Pathophysiology of the Post-Traumatic Confusional State and Post-Traumatic Amnesia: A Scoping ReviewDouglas I Katz, Yelena G Bodien, Afik Faerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate CancerPaymaneh D Malihi, Ryon P Graf, Angel Rodriguez, et al.
JAMA Oncology|July 7, 2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical TrialKaren A Autio, Robert Dreicer, Justine Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
JAMA Network Open|December 27, 2023
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational BurdenAndrea Necchi, Philippe E Spiess, Tiago Costa de Padua, et al.
The Oncologist|May 13, 2022
Variable Genomic Landscapes of Advanced Melanomas with Heavy PigmentationRichard S P Huang, Julie Y Tse, Lukas Harries, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2023
Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer TypesPashtoon M Kasi, Jessica K Lee, Lincoln W Pasquina, et al.
Pageof 25